The global Dental Bone Void Filler Market size is expected to reach USD 127.0 million by 2028, registering a CAGR of 5.6%, according to a new report by Grand View Research, Inc. The growth is attributable to the biological performance of materials, such as calcium phosphate-based bone substitutes that are biocompatible, have good volume maintenance over time, and are bioabsorbable. Dental professionals are at risk of contracting COVID-19 infection due to proximity with patients during the dental procedures. This factor has created fear among the dental professionals leading to reduced patient intake, which can, in turn, hamper the market growth.
Bone grafting is being widely practiced in dentistry as poor fixation and loosening of dental implants are common complications. Thus, void fillers are used to minimize these complications and facilitate cellular growth & targeted high-quality bone formation, as well as increase the contact interface with the graft. This results in stabilization and better fixation of dental implants. Such benefits are expected to boost market growth. The global market is also driven by the availability of advanced materials, such as hydroxyapatite. For instance, Osbone, hydroxyapatite, is a graft material indicated for augmentation of the atrophied alveolar ridge and filling bone defects. The benefit of Osbone includes a minimal residual risk of allergic and infections reactions., which, in turn, ensures long-term and fast stability of the scaffolding for bone generation. Such advantages increase the demand for the product thus boosting the market. Related Press Release@ Dental Bone Void Filler Market Report Dental Bone Void Filler Market Report Highlights
0 Comments
The global Intrathecal Pumps Market size is expected to reach USD 462.1 million by 2028, registering a CAGR of 5.1% over the forecast period, according to a new report by Grand View Research, Inc. Intrathecal pump is a highly efficient device that helps improve chronic pain conditions in patients with cancer and other related disorders. The increase in the prevalence of chronic pain conditions, the growing geriatric population, and the reduced or complete elimination of pain killers by patients are expected to contribute to the market growth. Intrathecal pumps are better than oral medications because they work directly in the Cerebrospinal Fluid (CSF), allowing drugs to be absorbed faster and more effectively.
Improved features, technological improvement, and a higher product demand will boost the market growth. Many global, as well as local key players in the market, are opting for different strategies. In February 2020, Flowonix Medical received the U.S. FDA approval to market its Prometra II Programmable Pump System. However, there are several drugs, which are not approved for intrathecal usage by the FDA. The FDA has also alerted patients and healthcare providers about the risk of using medications that have not been approved by the FDA. As a result of the COVID-19 pandemic, the healthcare system had to deal with a lot of challenges. All outpatient and elective interventional procedures were limited or stopped to lower the impact of the virus outbreak. Also, most chronic pain therapies were regarded as non-urgent. The market, however, is projected to experience gradual growth with all services being restored. Furthermore, the increase in the geriatric population, which is prone to chronic pain, has increased the product demand. According to the National Institute on Aging (NIA), the geriatric population would be around 72 million by 2030. Related Press Release@ Intrathecal Pumps Market Report Intrathecal Pumps Market Report Highlights
The global Polymerase Chain Reaction Market size is expected to reach USD 25.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 0.9% from 2021 to 2028. This is driven by an increase in demand for rapid diagnostic tests and technological advancements. Key players operating in the market are focusing on introducing novel and technologically advanced devices for PCR tests. For instance, in July 2017, Bio-Rad Laboratories launched droplet digital PCR Genome Edit Detection Assays to quantify the efficiency of CRISPR-Cas9 or any other genome using the technology of Bio-Rad’s droplet digital polymerase chain reaction. This technology has gained prominence over the past few years. Furthermore, the COVID-19 outbreak has increased the growth rate of dPCR technology. Several types of research activities are being conducted for proving the accuracy of the dPCR test. For instance, in March 2020, researchers of the Center for Advanced Measurement Science worked with Chongqing University in collaboration with the Centers for Disease Prevention and Control of Wuhan and Beijing for detecting the sensitivity of dPCR kits. In addition, two more studies were conducted in China that suggested improved sensitivity as compared to gold standard RT-qPCR. Moreover, in March 2020, Bio-Rad Laboratories developed a dPCR test for the detection of the SARS-CoV-2 virus. Various research initiatives being undertaken coupled with increasing collaborations between companies for the development of tests are factors anticipated to drive the growth of the segment. In May 2020, Xiamen University, in collaboration with the Chinese University of Hong Kong and University of Connecticut, was engaged in the development of an experimental procedure for developing and validating a qPCR assay for the detection of Symbiodiniaceae genera. Furthermore, sxtA-based qPCR tests were proved to be effective against Alexandrium catenella in 2019. Government initiatives undertaken to boost testing capacity are expected to drive the market. For instance, in September 2020, the National Institutes of Health offered USD 129.3 million under the Rapid Acceleration of Diagnostics (RADx) initiative to drive manufacturing and usage of RT-PCR. The growing number of tests conducted by governments to counter the COVID-19 pandemic is expected to act as a driver for qPCR and dPCR market. For instance, Iceland has conducted 135 tests per 1,000 population. The introduction of novel PCR such as plasmonic PCR in the PoC diagnostics platform is expected to be a disruptive technology, as existing PCR platforms are slow, expensive, and energy costly. Therefore, the development of lower-cost PoC technology with high accuracy is expected to reduce the procurement cost for medical use and overall laboratory cost of a patient in countries of Asia Pacific, North America, and Europe. Moreover, initiatives are undertaken by key players to enhance their product portfolios and global presence. For instance, in September 2020, Qiagen acquired NeuMoDx Molecular, Inc. for USD 248 million. The acquisition is anticipated to boost Qiagen’s PCR portfolio and enhance its global presence as well as customer access. Related Press Release@ Polymerase Chain Reaction Market Report Polymerase Chain Reaction Market Report Highlights
The global Urinary Drainage Bags Market size is expected to reach USD 2.6 billion by 2028, registering a CAGR of over 4.6% over the forecast period, according to a new report by Grand View Research, Inc. The increasing geriatric population, favorable reimbursement policies, and rising prevalence of urological diseases are the key factors driving the market. There has been a constant rise in the prevalence of urologic disorders, such as urinary retention, cystitis, benign prostatic hyperplasia, Urinary Incontinence (UI), and kidney stones, which lead to bladder dysfunction. A report published by the National Center for Biotechnology Information (NCBI) in 2020 states that the prevalence of acute urinary retention is more common in men than in women and around 10.00% of men in the age group 70 to 80 years is more likely to develop acute urinary retention. Therefore, such instances indicate that the demand for urinary drainage bags may increase, thereby propelling the market growth over the forecast period. The COVID-19 pandemic has restricted access to medical services, which has led to inadequate medical facilities for patients with various conditions. Older patients with multiple comorbidities are at a higher risk of acquiring COVID-19 due to low immunity. Older people majorly prefer using urinary drainage bags during hospital admissions due to several advantages. Therefore, a surge in hospital admission rate due to rising cases of COVID-19 is anticipated to propel the product demand to offer efficient patient care across hospital settings. Thus, the market is expected to witness significant and continuous growth post-pandemic. Related Press Release@ Urinary Drainage Bags Market Report Urinary Drainage Bags Market Report Highlights
The global Laboratory Supplies Market size is expected to reach USD 54.1 billion by 2028, expanding at a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Focus on R&D drives the demand for lab equipment market, thereby boosting the market growth. In June 2019, the D.O.D’s Defense Logistics Agency settled the bidding process for USD 312.0 million contracts, for lab equipment and supplies. There are instances of huge government spending in the category including White House’s budget of 2020 that provides USD 134.0 billion for federal R&D, including significant investments in R&D facilities and equipment. Laboratories have emerged as multipurpose research facilities in which various types of testing mechanisms, research analogies, and novel developments are carried out. This has also led to an increase in the demand for lab equipment and supplies market. Furthermore, the trend of research-based studies has been gaining traction over the past decade. This has resulted in the development of new laboratories in academic institutes, thereby boosting the market growth. Recently, clinical laboratories have also gone through major technological advancements. With intense R&D going in the field of the pathogenesis of diseases and personalized medicine, advanced diagnostics methods and tests are being implemented extensively. Technological improvements in instrumentation continue to bring real benefits that accrue from greater ease of use, increased capacity, speed of analysis, higher precision, operational efficiencies, enhanced reliability, improved safety, and numerous other intangibles. Related Press Release@ Laboratory Supplies Market Report Laboratory Supplies Market Report Highlights
The global Artificial Intelligence In Diagnostics Market size is expected to reach USD 5.8 billion by 2028 and is expected to expand at a CAGR of 32.8% over the forecast period, according to a new report by Grand View Research, Inc. Rising number of AI-based diagnostic startups in healthcare sector along with increasing investments by venture capitalists for development of newer and innovative technologies which can provide effective and fast results with respect to diagnostic processes is supporting the market growth.
Based on component, the software segment dominated the market with a share of 44.3% in 2020. This high share is attributable to the rising demand for AI-powered software tools and cloud-based solutions for diagnostic purposes. In addition, technological advancements in artificial intelligence-based software by integration of multiple data points such as CT, MRI, and genomics for precise diagnosis and detection are further propelling the overall growth and adoption. In 2020, based on diagnosis type, the neurology segment accounted for the highest revenue share in the market. The rising prevalence of neurological conditions and technological advances that would cater to the growing population with neurological problems are key factors bolstering segment growth. In addition, increasing investments by healthcare and technology players for the development of AI-powered diagnostic tools to cater to growing needs is further supporting the growth, thereby signifying higher revenue share. North America dominated the market with a revenue share of 55.9% in 2020 owing to various factors including ongoing developments in the field of artificial intelligence and diagnostics, presence of key players, rising number of technological advancements, and established healthcare sector in the region. In addition, growing adoption and awareness with respect to AI-powered solutions for better diagnostic procedures and precise data consolidation and analysis in North America is further supporting the higher revenue share. Moreover, the COVID-19 pandemic has positively impacted the market owing to the increasing implementation of artificial intelligence-based solutions in the rapid diagnosis of virus strains. In addition, the precise detection and diagnosis of viruses provided by these solutions are beneficial in reducing detection time and increasing the number of diagnostic procedures carried out during pandemic situations. Furthermore, the pandemic has also led to an increase in the adoption of technologically advanced solutions by healthcare facilities and others. Many players have collaborated with healthcare facilities for providing AI-based solutions for diagnostic purposes. Hence, increasing adoption and rising awareness regarding AI-based diagnostic solutions during the pandemic has provided a boost to the growth, and this trend in adoption is anticipated to continue in the coming years. Related Press Release@ Artificial Intelligence in Diagnostics Market Report Artificial Intelligence in Diagnostics Market Report Highlights
The global Intravenous Infusion Pumps Market size is expected to reach USD 8.4 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2021 to 2028. The introduction and development of specialty and smart pumps are imparting crucial growth of the market as they constitute Dose-error Reduction Software (DERS) and customized drug libraries. According to a study conducted by Mindray Medical Company in 2018, medical pumps are the most conventional hospital rentals equipment.
To improve the safety and efficacy of intravenous infusion pumps, the U.S. FDA took an initiative known as the Infusion Pump Improvement Initiative in 2010, which focuses on supporting the benefits of generic pumps and minimizing the risk associated with them at the same time. FDA also launched a website that gives peculiar information about medical pumps to the patients, users, and other stakeholders. Several government collaborative research projects like the Generic Infusion Pump Project are introduced that are aimed at creating new methods for manufacturers for developing software for intravenous medical pumps. National Institute of Standards and Technology is working in collaboration with NCCoE to manufacture wireless medical pumps and such incorporation of various government policies and regulations will in turn propel the market. The amalgamation of factors like the shift in technology, automation, and standardized dosing for the intravenous medical devices are anticipated to make therapy more convenient and user-friendly for patients. For instance, in May 2018, Baxter launched SPECTRUM IQ that allows patients records to be transferred directly from the EMR to the infusion system which is apt for home therapy as well as for therapies carried out in hospitals. The hematology disease indication segment is anticipated to grow fast over the forecast period. Rising cases of blood cancer are driving demand for blood transfusion through hematology, thereby driving the segment. North America dominated the market in 2019 and is anticipated to maintain its dominance over the forecast period. Increasing number of surgeries, rising cases of chronic diseases, and R&D in healthcare sector are driving the market in the region. Related Press Release@ Intravenous Infusion Pumps Market Report Intravenous Infusion Pumps Market Report Highlights
The global Near Infrared Imaging Market size is expected to reach USD 405.0 million by 2028, according to a new report by Grand View Research, Inc. expanding at a 9.3% CAGR during the forecast period. The growing use of near-infrared imaging due to advantages such as minimally invasiveness and high efficiency in diagnosing various conditions is anticipated to drive the near-infrared imaging market significantly during the forecast period. Growing incidences of chronic disorders, especially among the geriatric population is fueling the near infrared imaging market. Alzheimer’s disease, dementia, arthritis, chronic kidney disease, and diabetes, are some of the commonly prevalent diseases that require near infrared imaging for better diagnosis and further decision making for effective treatment. Expanding applications of the NIR technique in early diagnosis of various neurological conditions is expected to play a significant role in overall market growth. As per National Research University’s Higher School of Economics, neurological disorders are one of the leading causes of disability and death today. They were reported as the leading cause group of Disability Adjusted Life Years, which comprised 16.8% global deaths. Frequent introduction of technologically advanced systems is expected to have a significant impact on market growth. NIR is preferred as a process monitoring tool, especially in the pharmaceutical industry. Expanding applications of NIR in commercial operations and research activities in biopharmaceutical companies, as well as academic institutes, are expected to fuel the demand for advanced NIR systems in upcoming years. Related Press Release@ Near Infrared Imaging Market Report Near Infrared Imaging Market Report Highlights
The global Veterinary Orthopedics Market size is anticipated to reach USD 930.1 million by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.3% from 2021 to 2028. The growing pet population, the prevalence of pet obesity and arthritis, which may require orthopedic surgery, are expected to drive the market. Moreover, increasing technological advancements in veterinary devices is another driver expected to contribute to the market growth.
According to the American Pet Products Association (APPA), about 84.9 million American homes (67% of U.S. households) owned a pet in 2019. This number is significantly greater than 2017 statistics wherein nearly 60.2 million U.S. households had at least one pet dog. In 2019, Americans spent USD 95.7 billion on pets, which was USD 5.2 billion more than the expenditure in 2018. The rise in the number of pet owners and, subsequently, expenditure on pets, is boosting the animal health industry, including veterinary orthopedics. Owners are concerned about their pets and, hence, the demand for efficient treatment is rising. This trend is expected to continue, thus, fueling market growth during the forecast period. According to Association for Pet Obesity Prevention (APOP), 56% of dogs and 60% of cats were overweight or obese in the U.S., in 2018. Obesity increases pressure on joints and bones. According to APPA, nearly 20.8 million dogs in the U.S. had undergone orthopedic surgeries in 2016. The most common orthopedic surgeries carried out on canines were femoral head osteotomy, bones fracture repair, cruciate ligament repair, and medial patellar luxation. The prevalence of osteoarthritis in animals is increasing because of obesity, which is boosting demand for veterinary orthopedic devices and surgeries. According to Kingsbrook Animal Hospital, 20% of all dogs-regardless of age-in the U.S. had osteoarthritis in 2017. The COVID-19 pandemic significantly impacted the market, as the number of elective surgeries went down due to lockdown and quarantine measures. However, the market is anticipated to be driven by the resumption of elective surgeries. In March 2020, the Harmony Veterinary Center in compliance with government guidelines, suspended all its elective procedures, surgeries, and dentistry services during the COVID-19 outbreak. However, this does not change the underlying need for these procedures and the market is expected to grow significantly as surgeries return to pre-COVID numbers. Related Press Release@ Veterinary Orthopedics Market Report Veterinary Orthopedics Market Report Highlights
The global Cell Lysis & Disruption Market size is expected to reach USD 8.37 billion by 2028, registering a CAGR of 9.35% over the forecast period, according to a new report by Grand View Research, Inc. The anticipated revenue growth is attributed to accelerating the adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products. Technological developments in procedures involved in releasing cellular organelles have paved the way for the higher adoption of cell disruption methods.
As retrieval and purification of biopharmaceuticals involve cell disruption, a rise in demand for biopharma would lead to the subsequent growth of the market. In addition, advancements in the field of proteomics, metabolomics, and personalized medicine are expected to fuel progressive changes in this sector. However, the high costs of equipment coupled with the dearth of skilled professionals are expected to restrain revenue generation to a certain extent. The restraint can be addressed as the government organizations are releasing substantial funds to support development in the biotechnology sector. Enzymatic lysis, owing to higher biological specificity, is likely to register the fastest CAGR over the forecast period. Manufacturers are embracing the trend of providing synthetic enzymes and pre-formulated kits, which can be used for the extraction and purification of proteins, DNA, and RNA. Sonication instruments in the products available are expected to witness lucrative growth due to higher adoption rates as a result of the reliability on these instruments. Factors attributing to this reliability include complete control allowed on parameters and negligible maintenance. Among the physical methods, the high product yield obtained by sonication of the liquid sample is attributed to the larger revenue share of the ultrasonic homogenization method/technique. Asia Pacific will be the fastest-growing regional market from 2021 to 20285 due to lucrative opportunities offered by emerging nations, which has attracted investments from global firms in the region. Key companies are engaged in new product development and strategic alliances to maintain their market share. Related Press Release@ Cell Lysis & Disruption Market Report Cell Lysis & Disruption Market Report Highlights
|
Archives
October 2023
|